GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Dendreon Corporation (DNDN) [hlAlert]

Rating:
Underperform
DNDN
up 10,636.36 %

Dendreon Corporation (DNDN) rated Underperform by William Blair

Posted on: Friday,  Sep 16, 2011  1:25 PM ET by William Blair

William Blair rated Underperform Dendreon Corporation (NASDAQ: DNDN) on 09/16/2011, when the stock price was $11.81. Since
then, Dendreon Corporation has lost 99.07% as of 11/14/2014's recent price of $0.11.
If you would have followed this William Blair's recommendation on DNDN, you would have gained 10636.4% of your investment in 1155 days.

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. Through the use of antigen engineering and proprietary cell separation technologies, Dendreon develops therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer. In addition to its products for cancer, Dendreon also intends to pursue the application of its technologies in the fields of autoimmune diseases, allergies and infectious diseases.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/16/2011 1:25 PM Sell
None
11.81
as of 12/30/2011
1 Week down  -0.39 %
1 Month up  12.03 %
3 Months up  15.55 %
1 YTD up  35.64 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy